Drug Approval | March 01, 2022
Lupin launches Sevelamer Hydrochloride tablets in the United States
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
It will open new frontier for south-to-south collaboration and innovation transfer
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Key takeaways of recent quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
